IMR Press / FBL / Volume 29 / Issue 1 / DOI: 10.31083/j.fbl2901004
Open Access Original Research
Parkinson's Disease Diagnosis Using miRNA Biomarkers and Deep Learning
Show Less
1 REHS Program, San Diego Supercomputer Center, UC San Diego, La Jolla, CA 92093, USA
2 San Diego Supercomputer Center, UC San Diego, La Jolla, CA 92093, USA
3 BiAna, La Jolla, CA 92038, USA
4 CureScience Institute, San Diego, CA 92121, USA
5 Pacific Neuroscience Institute, Santa Monica, CA 90404, USA
6 Department of Neurosciences, UC San Diego, La Jolla, CA 92093, USA
*Correspondence: itsigeln@health.ucsd.edu (Igor F. Tsigelny)
Front. Biosci. (Landmark Ed) 2024, 29(1), 4; https://doi.org/10.31083/j.fbl2901004
Submitted: 25 July 2023 | Revised: 5 September 2023 | Accepted: 20 November 2023 | Published: 12 January 2024
Copyright: © 2024 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract

Background: The current standard for Parkinson’s disease (PD) diagnosis is often imprecise and expensive. However, the dysregulation patterns of microRNA (miRNA) hold potential as a reliable and effective non-invasive diagnosis of PD. Methods: We use data mining to elucidate new miRNA biomarkers and then develop a machine-learning (ML) model to diagnose PD based on these biomarkers. Results: The best-performing ML model, trained on filtered miRNA dysregulated in PD, was able to identify miRNA biomarkers with 95.65% accuracy. Through analysis of miRNA implicated in PD, thousands of descriptors reliant on gene targets were created that can be used to identify novel biomarkers and strengthen PD diagnosis. Conclusions: The developed ML model based on miRNAs and their genomic pathway descriptors achieved high accuracies for the prediction of PD.

Keywords
machine learning
Parkinson's disease
miRNA biomarkers
neural networks
deep learning
Figures
Fig. 1.
Share
Back to top